Impact of improved treatment success on the prevalence of TB in a rural community based on active surveillance.
Article
Dans Anglais
| IMSEAR
| ID: sea-110533
ABSTRACT
OBJECTIVE:
To study the impact of improved treatment outcome of a cohort of patients treated under DOTS strategy on the prevalence of pulmonary tuberculosis (TB) in the community.DESIGN:
The data from TB register of one Tuberculosis Unit (TU) in Tiruvallur district of Tamilnadu, and two TB disease surveys conducted in the same area during 1999-2003 were analysed. The successful treatment outcome was compared to the prevalence of TB in the subsequent cohort.RESULTS:
The proportion of patients who completed treatment successfully was 75.3% in the first cohort period. This higher proportion of treatment success among patients treated under DOTS in the first cohort period (1999-2001) compared to the 51-55% reported during SCC, resulted in a lower prevalence of smear-positive cases, irrespective of culture results observed in the survey conducted during 2001-2003 compared to that in the survey conducted during 1999-2001 (252 vs. 323 per 100,000; annual decline of 9%). Similarly, a decline in culture-positive cases, irrespective of smear results, was also observed (443 vs. 605; annual decline 11%).CONCLUSION:
The higher proportion of successful completion of treatment after DOTS implementation was associated with a substantial decline in the prevalence of TB. These findings showed that we are in the direction towards achieving the Millennium Development Goals (MDGs).
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Tuberculose
/
Femelle
/
Humains
/
Mâle
/
Protocoles cliniques
/
Surveillance de la population
/
Santé en zone rurale
/
Prévalence
/
Études de cohortes
/
Résultat thérapeutique
Type d'étude:
Etude d'étiologie
/
Guide de pratique
/
Etude d'incidence
/
Étude observationnelle
/
Étude de prévalence
/
Facteurs de risque
/
Étude de dépistage
Pays comme sujet:
Asie
langue:
Anglais
Année:
2008
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS